Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients

SUMMARY: Outcomes for melanoma patients with stage III disease differ widely even within the same subcategory. Molecular signatures that more accurately predict prognosis are needed to stratify patients according to risk. Proteomic analyses were used to identify differentially abundant proteins in e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pigment Cell Melanoma Res
Main Authors: Mactier, Swetlana, Kaufman, Kimberley L, Wang, Penghao, Crossett, Ben, Pupo, Gulietta M, Kohnke, Philippa L, Thompson, John F, Scolyer, Richard A, Yang, Jean Y, Mann, Graham J, Christopherson, Richard I
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285183/
https://ncbi.nlm.nih.gov/pubmed/24995518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12290
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki